Literature DB >> 12435275

Degradation of human thymidine kinase is dependent on serine-13 phosphorylation: involvement of the SCF-mediated pathway.

Po-Yuan Ke1, Che-Chuan Yang, I-Chun Tsai, Zee-Fen Chang.   

Abstract

The expression level of human thymidine kinase (hTK) is regulated in a cell-cycle-dependent manner. One of the mechanisms responsible for the fluctuation of TK expression in the cell cycle can be attributed to protein degradation during mitosis. Given the facts that cell-cycle-dependent proteolysis is highly conserved in all eukaryotes and yeast cells are an excellent model system for protein-degradation study, here we report on the use of Saccharomyces cerevisiae and Schizosaccharomyces pombe to investigate the degradation signal and mechanism required for hTK degradation. We found that the stability of hTK is significantly reduced in mitotic yeasts. Previously, we have observed that Ser-13 is the site of mitotic phosphorylation of hTK in HeLa cells [Chang, Huang and Chi (1998) J. Biol. Chem. 273, 12095-12100]. Here, we further provide evidence that the replacement of Ser-13 by Ala (S13A) renders hTK stable in S. pombe and S. cerevisiae. Most interestingly, we demonstrated that degradation of hTK is impaired in S. cerevisiae carrying a temperature-sensitive mutation in the proteasomal gene pre1-1 or the Skp1-Cullin-1/CDC53-F-box (SCF) complex gene cdc34 or cdc53, suggesting the contribution of the SCF-mediated pathway in hTK degradation. As phosphorylation is a prerequisite signal for SCF recognition, our results implied that phosphorylation of Ser-13 probably contributes to the degradation signal for hTK via the SCF-mediated proteolytic pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12435275      PMCID: PMC1223163          DOI: 10.1042/BJ20021335

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Whose end is destruction: cell division and the anaphase-promoting complex.

Authors:  W Zachariae; K Nasmyth
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

2.  Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors.

Authors:  Y K Kim; A S Lee
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells.

Authors:  M Ito; S E Conrad
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

4.  Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis.

Authors:  M G Kauffman; T J Kelly
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells.

Authors:  M G Kauffman; P A Rose; T J Kelly
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

6.  Translational repression of endogenous thymidine kinase mRNA in differentiating and arresting mouse cells.

Authors:  M Knöfler; C Waltner; E Wintersberger; E W Müllner
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

7.  Identification of a G1-S-phase-regulated region in the human thymidine kinase gene promoter.

Authors:  H H Roehl; S E Conrad
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

8.  Regulation of human thymidine kinase during the cell cycle.

Authors:  J L Sherley; T J Kelly
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  The regulation of thymidine kinase in HL-60 human promyeloleukemia cells.

Authors:  Z F Chang; D Y Huang
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

10.  Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival.

Authors:  W Heinemeyer; J A Kleinschmidt; J Saidowsky; C Escher; D H Wolf
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  5 in total

1.  Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway.

Authors:  Po-Yuan Ke; Zee-Fen Chang
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.

Authors:  David A Plotnik; Lena J McLaughlin; Kenneth A Krohn; Jeffrey L Schwartz
Journal:  Nucl Med Biol       Date:  2012-05-05       Impact factor: 2.408

3.  A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.

Authors:  Kiran Kumar Jagarlamudi; Laura Moreau; Sara Westberg; Henrik Rönnberg; Staffan Eriksson
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

4.  Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.

Authors:  Roberta Sala; Quang-Dé Nguyen; Chirag B K Patel; David Mann; Joachim H G Steinke; Ramon Vilar; Eric O Aboagye
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

5.  A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.

Authors:  J Kiran Kumar; A C Aronsson; G Pilko; M Zupan; K Kumer; T Fabjan; J Osredkar; S Eriksson
Journal:  Tumour Biol       Date:  2016-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.